Evolution of Helicobacter pylori therapy from a meta-analytical perspective

Helicobacter

Volumn 12, Issue SUPPL. 2, 2007, Pages 50-58

  Gisbert, Javier P ^a   Pajares, Ramón ^b   Pajares, José María ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Amoxicillin; Bismuth; Clarithromycin; Levofloxacin; Proton pump inhibitor; Ranitidine bismuth citrate; Rescue; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH DERIVATIVE; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; NITROIMIDAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE;

BACTERIAL INFECTION; DOSE RESPONSE; DRUG EFFICACY; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; GASTRITIS; HELICOBACTER INFECTIONS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PROTON PUMP INHIBITORS;

HELICOBACTER PYLORI;

EID: 35948981603     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00576.x     Document Type: Review

References (62)

1. Morozov IA. Helicobacter pylori was discovered in Russia in 1974. In : Marshall BJ, ed. Helicobacter Pioneers. Firsthand Accounts from the Scientists Who Discovered Helicobacters 1892-1982. Melbourne : Blackwell Science Asia, 2002 105 19.
2. Solano J. Tratamiento de la úlcera de estómago y duodeno con la asociación de suero y penicilina. Rev Esp Enferm Ap Digest Y Nutric 1949 6 : 763 9.
3. Rigas B, Papavassiliou D. John Lykoudis: the general practitioner in Greece who in 1958 discovered the etiology of, and a treatment for, peptic ulcer disease. In : Marshall BJ, ed. Helicobacter Pioneers. Firsthand Accounts from the Scientists Who Discovered Helicobacters 1892-1982. Melbourne : Blackwell Science Asia, 2002 75 89.
4. Xiao S-D, Yao S, Liu W-Z. How we discovered in China in 1972 that antibiotics cure peptic ulcer. In : Marshall BJ, ed. Helicobacter Pioneers. Firsthand Accounts from the Scientists Who Discovered Helicobacters 1892-1982. Melbourne : Blackwell Science Asia, 2002 99 105.
5. Marshall BJ. The discovery that Helicobacter pylori, a spiral bacterium, caused peptic ulcer disease. In : Marshall BJ, ed. Helicobacter Pioneers. Firsthand Accounts from the Scientists Who Discovered Helicobacters 1892-1982. Melbourne : Blackwell Science Asia, 2002 165 203.
6. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 1986 39 : 353 65.
7. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988 2 : 1437 42.
8. Coghlan JG, Gilligan D, Humpries H, et al. Campylobacter pylori and recurrence of duodenal ulcers: a 12 month follow-up study. Lancet 1987 ii : 1109 11.
9. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associate with eradication of Helicobacter pylori. Lancet 1990 ii : 1233 5.
10. Unge P, Gad A, Gnarpe H, Olsson J. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol Suppl 1989 167 : 49 54.
11. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994 272 : 65 9.
12. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992 87 : 1716 27.
13. Pipkin GA, Dixon JS, Williamson R, Wood JR. Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review. Helicobacter 1997 2 : 159 71.
14. Hopkins RJ. Current FDA-approved treatments for Helicobacter pylori and the FDA approval process. Gastroenterology 1997 113 : S126 30.
15. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997 41 : 8 13.
16. Unge P. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 1997 113 : S131 48.
17. Borody T, Cole P, Noonan S, et al. Long term Campylobacter pylori recurrence post-eradication. Gastroenterology 1988, 94 (5), Part 2 : A43.
18. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993 88 : 1860 4.
19. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short-term low-dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 1993 104 : 40 A.
20. Lamouliatte H, Cayla R, Regland F, et al. Amoxicillin - clarithromycin - omeprazole: the best therapy for Helicobacter pylori infection. Acta Gastroenterol Belg 1993 56 : A139.
21. Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996 1 : 138 44.
22. Lind T, Megraud F, Unge P, et al. The MACH 2 Study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999 116 : 248 53.
23. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002 16 : 167 80.
24. Gisbert JP, Calvet X, Gomollon F, Mones J. Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference. Med Clin (Barc) 2005 125 : 301 16.
25. Unge P. Review of Helicobacter pylori eradication regimens. Scand J Gastroenterol Suppl 1996 215 : 74 81.
26. Buzas GM, Jozan J. Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002. Orv Hetil 2004 145 : 2035 41.
27. Taylor JL, Zagari M, Murphy K, Freston JW. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. Arch Intern Med 1997 157 : 87 97.
28. Schmid CH, Whiting G, Cory D, Ross SD, Chalmers TC. Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials. Am J Ther 1999 6 : 25 36.
29. Gisbert JP, Gonzalez L, Calvet X, et al. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000 14 : 1319 28.
30. Gisbert JP, Pajares JM. Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis 2001 19 : 134 43.
31. Huang J, Hunt RH. The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Aliment Pharmacol Ther 1999 13 : 719 29.
32. Buzas GM. Eradication of Helicobacter pylori infection in Hungary (1993-2002): a meta-analysis. Orv Hetil 2003 144 : 1077 83.
33. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment Pharmacol Ther 1999 13 : 857 64.
34. Hentschel E, Brandstatter G, Dragosic B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and recurrence of duodenal ulcer. N Engl J Med 1993 328 : 308 12.
35. Gisbert JP. Potent gastric acid inhibition in Helicobacter pylori eradication. Drugs 2005 65 : 83 96.
36. 2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons. Z Gastroenterol 1996 34 : 267 72.
37. 2-receptor antagonists - their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther 2003 18 : 757 66.
38. Dobrucali A, Canbakan B, Canbakan M, et al. [Meta-analysis of determining the pathogen eradicating efficacy of various therapeutic regimens in Helicobacter pylori infection]. Wien Med Wochenschr 1998 148 : 464 8.
39. Bazzoli F, Pozzato P, Zagari M, et al. Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. Helicobacter 1998 3 : 195 201.
40. Gisbert JP, Khorrami S, Calvet X, Pajares JM. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2004 16 : 89 99.
41. Gisbert JP, Khorrami S, Calvet X, Pajares JM. Systematic review: rabeprazole-based therapies in Helicobacter pylori eradication. Aliment Pharmacol Ther 2003 17 : 751 64.
42. Gisbert JP, Pajares JM. Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis. Dig Liver Dis 2004 36 : 253 9.
43. Wang X, Fang JY, Lu R, Sun DF. A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori. Digestion 2006 73 : 178 86.
44. Vergara M, Vallve M, Gisbert JP, Calvet X. Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2003 18 : 647 54.
45. Vallve M, Vergara M, Gisbert JP, Calvet X. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Aliment Pharmacol Ther 2002 16 : 1149 56.
46. Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000 14 : 603 9.
47. Fischbach LA, van Zanten S, Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004 20 : 1071 82.
48. Buring SM, Winner LH, Hatton RC, Doering PL. Discontinuation rates of Helicobacter pylori treatment regimens: a meta-analysis. Pharmacotherapy 1999 19 : 324 32.
49. Gene E, Calvet X, Azagra R, Gisbert JP. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 2003 17 : 1137 43.
50. Gisbert JP, Pajares JM, Valle J. Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review. Helicobacter 1999 4 : 58 66.
51. Gisbert JP, Gonzalez L, Calvet X. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter 2005 10 : 157 71.
52. Dore MP, Leandro G, Realdi G, Sepulveda AR, Graham DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 2000 45 : 68 76.
53. van der Wouden EJ, Thijs JC, van Zwet AA, Sluiter WJ, Kleibeuker JH. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis. Am J Gastroenterol 1999 94 : 1751 9.
54. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol 2002 31 : 128 39.
55. Suzuki T, Matsuo K, Ito H, et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med 2006 119 : 217 24.
56. Janssen MJ, Laheij RJ, de Boer WA, Jansen JB. Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication. Aliment Pharmacol Ther 2005 21 : 341 5.
57. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003 17 : 99 109.
58. Gisbert JP, Pajares JM. Review article: Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther 2002 16 : 1047 57.
59. Croom KF, Goa KL. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs 2003 63 : 2769 802.
60. Gisbert JP, Pajares JM. Helicobacter pylori 'rescue' therapy after failure of two eradication treatments. Helicobacter 2005 10 : 363 72.
61. Gisbert JP, Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006 23 : 35 44.
62. Saad RJ, Schoenfeld P, Kim HM, Chey WD. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol 2006 101 : 488 96.